|
NEK7 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.862900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.154400E-02 |
| Normal-vs-Stage2 |
5.283800E-01 |
| Normal-vs-Stage3 |
1.900020E-02 |
| Normal-vs-Stage4 |
3.89179999999989E-05 |
| Stage1-vs-Stage2 |
7.664600E-01 |
| Stage1-vs-Stage3 |
3.203600E-01 |
| Stage1-vs-Stage4 |
4.578500E-03 |
| Stage2-vs-Stage3 |
3.822400E-01 |
| Stage2-vs-Stage4 |
1.138570E-01 |
| Stage3-vs-Stage4 |
2.541600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.744700E-03 |
| Normal-vs-AfricanAmerican |
1.186490E-04 |
| Normal-vs-Asian |
9.881800E-01 |
| Caucasian-vs-AfricanAmerican |
3.025800E-02 |
| Caucasian-vs-Asian |
5.187000E-01 |
| AfricanAmerican-vs-Asian |
8.612100E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.350100E-02 |
| Normal-vs-Female |
8.813300E-04 |
| Male-vs-Female |
2.175600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.976000E-02 |
| Normal-vs-Age(41-60Yrs) |
3.662500E-02 |
| Normal-vs-Age(61-80Yrs) |
5.783900E-03 |
| Normal-vs-Age(81-100Yrs) |
1.167990E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.536200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.407000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.743600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.396400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.983000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.174400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.123600E-01 |
| Normal-vs-Grade 2 |
3.091000E-01 |
| Normal-vs-Grade 3 |
6.434000E-04 |
| Normal-vs-Grade 4 |
1.66136999999456E-05 |
| Grade 1-vs-Grade 2 |
8.206200E-01 |
| Grade 1-vs-Grade 3 |
2.387600E-01 |
| Grade 1-vs-Grade 4 |
4.003600E-02 |
| Grade 2-vs-Grade 3 |
3.443900E-02 |
| Grade 2-vs-Grade 4 |
7.772500E-04 |
| Grade 3-vs-Grade 4 |
5.654400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.479200E-01 |
| Normal-vs-ccB subtype |
9.335300E-03 |
| ccA subtype-vs-ccB subtype |
1.999780E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.782100E-02 |
| Normal-vs-N1 |
6.907800E-01 |
| N0-vs-N1 |
7.625400E-01 |
|
|
